-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The context in which breast cancer occurs — the interaction between a patient's body mass index, tumor size, and cancer-specific proteins — is important
In recent decades, significant advances in diagnosis and treatment have improved survival rates
Now, the study at Lund University in Sweden has enhanced an understanding
The results of the new study are based on about 1,000 breast cancer patients
"We found that if the patient is of normal weight, or the tumor is small, it is good to have little or no Caveolin-1 in the cells around the tumor, but if the patient is overweight or the tumor is large, the opposite is true
This finding needs further research to confirm, but the results suggest that caveolin-1 protein can act as a marker, providing a more precise prognosis and supporting
"Our study shows that it's important to focus more on the patient's characteristics, not just the various aspects
Article title
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
